HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vegans Must Take A Vitamin B12 Supplement Every Day, Says German Nutrition Society As It Raises NRV

Executive Summary

As it raises the nutrient reference value for vitamin B12, the German Nutrition Society recommends that vegans take a supplement every day to address deficiencies resulting from vegan diets. The Vegan Society Germany, however, while supporting the level raise, disputes the claim that plant-based diets cannot supply the required amount of the vitamin. 

You may also be interested in...



Dermapharm Expands International Herbals And Supplements Capacity With Two Acquisitions

German generics and OTC specialist Dermapharm has snapped up two firms that it said would enable it to boost its international presence. 

Germany’s OTC Market in 2018: Online Sees Double-Digit Growth, Bionorica’s Canephron Uno Tops New Launches

Germany's online channel continued to expand to expand in 2018, with OTC product sales via mail-order pharmacy growing almost 10-times faster than through bricks-and-mortar pharmacy. Meanwhile, GSK's Voltaren brand was top-seller through both channels and Bionorica's Canephron Uno was the best-selling launch during the 12 months. 

Surviving The Dark German Winter: Four New Dietary Supplements Containing Vitamin D

To help Germans struggling through the dark winter months, Hevert, Cefak, Stada and Doppelherz have all released vitamin D supplements onto the German market.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148549

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel